Zenith Health Care Ltd Board Meeting

5.2
(-4.94%)
Jul 23, 2024|03:48:00 PM

Zenith Health CORPORATE ACTIONS

24/07/2023calendar-icon
23/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting20 Jul 202411 Jul 2024
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 a Meeting of the Board of Directors of the Company will be held on Saturday 20th July 2024 at the Registered Office of the Company at 504 Iscon Elegance Nr. Ananddham Jain Derasar Prahladnagar Cross Road S.G. Road Ahmedabad - 380 015 to transact following business; 1. To consider and approve the unaudited financial results of the Company for the quarter ended on 30th June 2024. 2. Any other item with the permission of the Chair and Majority of Directors. Unaudited Financial Result for the Quarter ended 20th July, 2024. (As per BSE Announcement Dated on 20/07/2024)
Board Meeting29 May 202420 May 2024
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations And Disclosure Requirements) Regulations2015 a Meeting of the Board of Directors of the Company will be held on Wednesday 29th May 2024 at the Registered Office of the Company. Outcome of the Meeting of Board of Directors held on 29th May, 2024 Consideration and Approval of Audited Financial Result for the Quarter and Year ended 31st March, 2024 and Other Matters. Standalone Audited Financial Result for the Quarter and Year ended on 31.03.2024. (As Per BSE Announcement Dated on 29.05.2024)
Board Meeting12 Feb 20241 Feb 2024
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Zenith Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia To consider and approve the unaudited financial results of the company for the quarter and nine month ended on December 312023. any other matter with the permission of the Chair Outcome of the Meeting of the Board of Directors held today, February 12, 2024 with Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December, 2023 (As Per BSE Announcement dated on 12.02.2024)
Board Meeting6 Nov 202326 Oct 2023
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 a Meeting of the Board of Directors of the Company will be held on Monday 06th November 2023 at the Registered Office of the Company at 504 Iscon Elegance Nr. Ananddham Jain Derasar Prahladnagar Cross Road S.G. Road Ahmedabad - 380 015 to transact following business; 1.To consider and approve the unaudited financial results of the Company for the quarter and half year ended on 30th September 2023. 2.To consider and approve the related party transactions disclosure under regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) 2015 for half year ended 30th September 2022. 3.Any other matter with the permission of the Chair. With reference to the above subject, we hereby submit the following outcome of the Meeting of the Board of Directors held today, November 06, 2023 at 3:00 p.m. at the Registered Office of the Company and concluded at 4.00 p.m.: 1.The Board considered and approved unaudited Standalone Financial Statement for quarter and Six months ended 30th September, 2023 along with Limited Review Report. 2.Considered & approved disclosure of Related Party Transaction u/r 23 (9) of SEBI LODR, 2015. The Board consider and approved unaudited Standalone Financial Statement for quarter and half year ended 30th September, 2023 along with Limited Review Report. (As Per BSE Announcement Dated on 06/11/2023)
Board Meeting31 Aug 202321 Aug 2023
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2023 inter alia to consider and approve Zenith Healthcare Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2023 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday August 31 2023 transact following business; 1.To call 29th Annual General Meeting of the Company and decide the time date day and venue of the meeting. 2.To consider and approve Notice of 29th Annual General Meeting Directors Report for the year ending 31st March 2023. 3.To Appoint M/s. Kamlesh M Shah & CO. PCS as Scrutinizers for e.voting process to be conducted at the ensuing AGM of the company to be held through OAVM. 4. To fix the date of Book Closure of the Company. 5. Any other item with the permission of the Chair and Majority of Directors. Outcome Of Board Meeting 1. Approved and took on record the Notice of AGM & Director Report. 2. AGM of the Company will be held on 26th September, 2023 at 10:30 A.M. through VC/ OAVM. 3. The Company has fixed, September 19, 2023 as Record Date for the purpose of determining the members eligible to vote on the resolutions set out in the Notice of the AGM or to attend the AGM. 4. The Register of Members & Share Transfer Books of the Company will remain closed from Wednesday, September 20, 2023 to Tuesday, September 26, 2023 (both days inclusive). (As Per BSE Announcement dated on 31.08.2023)
Board Meeting12 Aug 20232 Aug 2023
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Zenith Healthcare Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve the unaudited Financial Results for the Quarter ended June 30 2023. Outcome of Board Meeting held on 12th August 2023 for the Unaudited Financial Results of the Company for the quarter ended on 30th June, 2023. (As per BSE Announcement Dated on 12/08/2023)

Zenith Health: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.